Search Results - "Malik, Raleigh"

938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes by MALIK, RALEIGH E., MODY, REEMA, LAGE, MAUREEN J., BOYE, KRISTINA

“…Onjective: Examine the relationship between timing of initiation on a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and HbA1c. Methods: The IBM…”
Get full text

Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program by Frías, Juan Pablo, Galindo, Rodolfo J, Wang, Hui, Malik, Raleigh E, Chivukula, K Karthik, Maldonado, Juan M

“…Abstract Context Efficacy and safety of tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist,…”
Get full text

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11 by Bonora, Enzo, Frias, Juan P., Tinahones, Francisco J., Van, Joanna, Malik, Raleigh E., Yu, Zhuoxin, Mody, Reema, Bethel, Angelyn, Kwan, Anita Y. M., Cox, David A.

“…Aim To evaluate the impact of dulaglutide 3.0 and 4.5 mg versus 1.5 mg on body weight in patients with type 2 diabetes (T2D) based on exploratory analyses of…”
Get full text

The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes by Boye, Kristina S., Mody, Reema, Lage, Maureen J., Malik, Raleigh E.

“…This study examines the relationship between timing of initiation on a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glycosylated hemoglobin (HbA1c)…”
Get full text

Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice by Mody, Reema, Manjelievskaia, Janna, Marchlewicz, Elizabeth H., Malik, Raleigh E., Zimmerman, Nicole M., Irwin, Debra E., Yu, Maria

“…Greater medication adherence and persistence have been associated with improved glycemic control in patients with type 2 diabetes mellitus. This study compared…”
Get full text

Maternal and postweaning diet interaction alters hypothalamic gene expression and modulates response to a high-fat diet in male offspring by Page, Kathleen C, Malik, Raleigh E, Ripple, Joshua A, Anday, Endla K

“…Epidemiological data and results from animal studies indicate that imbalances in maternal nutrition impact the expression of metabolic disorders in the…”
Get more information

Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review by Robinson, Susan, Boye, Kristina S., Mody, Reema, Strizek, Alena Antonie, Konig, Manige, Malik, Raleigh E., Kennedy-Martin, Tessa

“…Introduction Randomized controlled trials (RCTs) have demonstrated the efficacy of dulaglutide in adults with type 2 diabetes mellitus (T2DM), but results may…”
Get full text

Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11 by Frias, Juan P., Bonora, Enzo, Cox, David A., Bethel, M. Angelyn, Kwan, Anita Y.M., Raha, Sohini, Malik, Raleigh E.

“…The AWARD‐11 trial demonstrated the safety and efficacy of dulaglutide 3.0 and 4.5 mg compared to dulaglutide 1.5 mg in patients with type 2 diabetes…”
Get full text

Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments by Boye, Kristina S., Jordan, Jessica B., Malik, Raleigh E., Currie, Brooke M., Matza, Louis S.

“…Introduction The administration of medications targeting type 2 diabetes mellitus (T2D) has evolved over time. As injection delivery systems continue to…”
Get full text

LHX3 interacts with inhibitor of histone acetyltransferase complex subunits LANP and TAF-1β to modulate pituitary gene regulation by Hunter, Chad S, Malik, Raleigh E, Witzmann, Frank A, Rhodes, Simon J

“…LIM-homeodomain 3 (LHX3) is a transcription factor required for mammalian pituitary gland and nervous system development. Human patients and animal models with…”
Get full text

The role of DNA methylation in regulation of the murine Lhx3 gene by Malik, Raleigh E., Rhodes, Simon J.

“…LHX3 is a LIM-homeodomain transcription factor with critical roles in pituitary and nervous system development. Mutations in the LHX3 gene are associated with…”
Get full text

Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association–cardiac safety research consortium cosponsored think tank by Seifert, Harry A., Malik, Raleigh E., Bhattacharya, Mondira, Campbell, Kevin R., Okun, Sally, Pierce, Carrie, Terkowitz, Jeffrey, Turner, J. Rick, Krucoff, Mitchell W., Powell, Gregory E.

“…This white paper provides a summary of the presentations and discussions from a think tank on “Enabling Social Listening for Cardiac Safety Monitoring” trials…”
Get full text

Model of pediatric pituitary hormone deficiency separates the endocrine and neural functions of the LHX3 transcription factor in vivo by Colvin, Stephanie C, Malik, Raleigh E, Showalter, Aaron D, Sloop, Kyle W, Rhodes, Simon J

“…The etiology of most pediatric hormone deficiency diseases is poorly understood. Children with combined pituitary hormone deficiency (CPHD) have insufficient…”
Get full text

A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency by Bechtold-Dalla Pozza, Susanne, Hiedl, Stefan, Roeb, Julia, Lohse, Peter, Malik, Raleigh E, Park, Soyoung, Durán-Prado, Mario, Rhodes, Simon J

“…Recessive mutations in the LHX3 homeodomain transcription factor gene are associated with developmental disorders affecting the pituitary and nervous system…”
Get more information

Mechanistic investigation of 9-bromoanthracene photodimers as initiators in atom transfer radical polymerization by Roof, Amanda C., Tillman, Eric S., Malik, Raleigh E., Roland, Alissa M., Miller, Daniel J., Sarry, Louis R.

“…Mechanistic pathways accounting for the lack of control in polymerizations employing photodimers of 9-bromoanthracene as alkyl halide initiators in atom…”
Get full text

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11) by Frias, Juan P, Bonora, Enzo, Nevarez Ruiz, Luis, Li, Ying G, Yu, Zhuoxin, Milicevic, Zvonko, Malik, Raleigh, Bethel, M Angelyn, Cox, David A

“…To compare efficacy and safety of dulaglutide at doses of 3.0 and 4.5 mg versus 1.5 mg in patients with type 2 diabetes inadequately controlled with metformin…”
Get full text

Tirzepatide versus Semaglutide 2.4 mg for People with Obesity or Overweight and Type 2 Diabetes by Hankosky, Emily, Brumm, Julia Fraseur, Malik, Raleigh, Niemeyer, Anthony, Wang, Fangyu, Zhang, Xiaotian Michelle, He, Xuanyao

“…Background: Tirzepatide is a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist under investigation for chronic weight…”
Get full text

790-P: The Effect of Tirzepatide vs. Placebo on Changes and Shifts in BMI Category in Adults with Type 2 Diabetes-A Post Hoc Analysis of the SURMOUNT-2 Study by Galindo, Rodolfo J, Lazarus, Ethan, Wang, Hui, Garcia-Perez, Luis-Emilio, Zhang, Michelle X, Grant, Gary, Malik, Raleigh

“…Tirzepatide (TZP) is a GIP and GLP-1 receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight…”
Get full text

Evaluating Health-Related Quality of Life With Tirzepatide in the SURMOUNT-1 Study by Poon, Jiat Ling, Zhang, Shuyu, d, Janet, Malik, Raleigh, Stefanski, Adam

“…Background: In SURMOUNT-1, a phase 3, 72-week, randomized, double-blind clinical trial in participants with obesity, tirzepatide, a novel glucose-dependent…”
Get full text

Abstract 15280: Does Weight Reduction Drive the Reduction in Blood Pressure in People Living With Obesity Treated With Tirzepatide?: Insights From SURMOUNT-1 Study by Sattar, Naveed, de Lemos, James A, Linetzky, Bruno, Sharma, Palash, Malik, Raleigh, Bunck, Mathijs, Ahmad, Nadia, Stefanski, Adam

“…Abstract only Background: Tirzepatide (TZP) is a GIP/GLP-1 receptor agonist indicated for the treatment of type 2 diabetes and in development for chronic…”
Get full text